Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 84 clinical trials
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

The current study is a case control study involving comparisons of tissue interstitial fluid from breast cancer and adjacent non-cancerous tissue as well as that from benign breast lesion and its adjacent non-diseased tissue for a distinguishable breast cancer profile. The purpose of this research is to collect fresh breast …

invasive breast cancer
core needle biopsy
breast carcinoma
mastectomy
  • 4 views
  • 03 May, 2022
  • 1 location
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

if plasma hydroxymethylation signatures are more sensitive than conventional tumor markers in identifying clinically detectable recurrence at 1 year after surgery.

adenocarcinoma
colorectal adenocarcinoma
metastasis
  • 1 views
  • 16 Feb, 2022
  • 1 location
Concordance Between Liquid and Tissue Biopsy

symptoms of breast cancer recurrence. It may also provide information on tumor markers (hormone receptors, HER2) that can guide treatment decisions. The goal of this study is to determine whether blood

erbb2
tumor cells
HER2
mammogram
  • 0 views
  • 12 Sep, 2021
  • 1 location
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma (PEP-C)

urine. The recent study of urinary exosomes is a promising topic for analyzing tumor markers in urine. The investigator's goal is to develop a reliable technique for detecting tumor exosomes in urine in

clear cell renal cell carcinoma
nephrectomy
cancer
tumor markers
carcinoma
  • 0 views
  • 24 Jul, 2022
  • 1 location
Ovarium Cancer Detection by TEP's and ctDNA

) DNA and circulating tumor cells, but none of these have been implemented for primary (multiclass) cancer diagnostics. Protein tumor markers have been used for decades in diagnosis and monitoring of

tumor cells
cancer of the ovary
tumor markers
  • 15 views
  • 12 Feb, 2022
  • 3 locations
Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System (CTCs)

> The secondary objective is to compare the multicolor flow cytometry results with data of ultrasound, CT and/or MRI, serum tumor markers, and immunohistochemical studies in patients with

breast cancer
ovarian cancer
cancer chemotherapy
Accepts healthy volunteers
laparoscopy
  • 0 views
  • 11 May, 2022
  • 1 location
Personalised Disease Monitoring in Metastatic Breast Cancer

evidence indicates that tumour markers such as circulating tumour DNA (ctDNA), thymidine kinase 1 (TK1) and cancer antigen 15-3 (CA15-3) may be useful for disease monitoring in the metastatic setting

  • 0 views
  • 28 Nov, 2021
  • 7 locations
The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring

therapy and determining whether exosome ALK fusion could assess the curative effect more accurately than imaging examination and tumor markers. Thirdly, FISH diagnosed EML4-ALK positive NSCLC patients

  • 0 views
  • 25 Jan, 2021
  • 1 location
Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer

cancer. Therefore, a diagnostic algorithm will be developed using ct-DNA and TEPs as liquid biomarkers in combination with the existing ultrasound models (RMI and IOTA-models) and tumor markers

tumor cells
cancer of the ovary
cancer antigen 125
  • 0 views
  • 31 Jul, 2021
  • 4 locations
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

available (GeneXpert® Bladder Cancer Detection, Cepheid International, Sunnyvale, CA, USA) for the measurement of mRNA bladder tumor markers in the urine. The diagnostic accuracy of this test has been

bladder cancer
spinal cord
cancer
bladder tumor
spinal cord disorder
  • 18 views
  • 21 Mar, 2022
  • 1 location